NCT05509543View on ClinicalTrials.gov

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

October 22, 2022

Study Completion Date

December 18, 2023

Conditions

Pharmacokinetics

Interventions

DRUG

IY-NT-T

Ilaprazole 20mg

DRUG

IY-NT-R

Ilaprazole 10mg

Trial Locations (1)

08756

H plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY